E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
Idiopathic environmental intolerances (IEI): from molecular epidemiology to molecular medicine.
De Luca, C, Scordo, G, Cesareo, E et al. · Indian journal of experimental biology · 2010
Quick Summary
Some people with ME/CFS and related conditions may have difficulty processing chemicals, metals, and other substances they encounter in the environment because of inherited or acquired differences in how their bodies handle these toxins. This review suggests that genetic variations affecting enzymes responsible for detoxifying chemicals, combined with problems in the body's antioxidant systems, might explain why some people react strongly to very small amounts of environmental exposures. Understanding these biological mechanisms could help develop personalized treatments.
Why It Matters
This review provides a biological framework linking genetics, detoxification capacity, and chemical sensitivity in ME/CFS and related syndromes, potentially moving these conditions from 'medically unexplained' to mechanistically grounded diagnoses. If the proposed mechanisms are validated, it could enable genetic and biochemical testing to identify at-risk individuals and guide targeted antioxidant or chelation therapies.
Observed Findings
- Polysymptomatic multi-organ syndromes in IEI conditions are triggered by exposure to chemicals and metals at concentrations well below standard environmental reference levels.
- Genetic polymorphisms in xenobiotic-metabolizing enzyme genes are postulated to vary among individuals with IEI.
- Oxidative stress and impaired antioxidant homeostasis are proposed to contribute to chronic cellular and tissue damage correlating with clinical symptoms.
- Epigenetic factors are suggested to play a role in susceptibility to environment-associated pathologies alongside genetic predisposition.
Inferred Conclusions
- Inherited or acquired impairment of xenobiotic metabolism, driven by genetic polymorphisms and epigenetic changes, is a plausible mechanism underlying IEI susceptibility.
- Free radical/antioxidant imbalance may both regulate detoxifying enzyme function and directly cause oxidative cellular damage linked to IEI symptoms.
- Systematic molecular epidemiological and pharmacogenomic research is necessary to establish biomarkers, confirm mechanisms, and develop individualized antioxidant- or chelator-based therapies.
Remaining Questions
- Which specific xenobiotic-metabolizing enzyme polymorphisms are most prevalent in ME/CFS and IEI populations, and do they correlate with disease severity or symptom profiles?
- How do epigenetic modifications interact with genetic predisposition to regulate detoxifying enzyme expression in IEI?
What This Study Does Not Prove
This review does not establish causality or provide empirical evidence from original research; it synthesizes existing hypotheses rather than testing them. The proposed genetic and oxidative stress mechanisms remain theoretical and require prospective studies with biochemical validation, genetic sequencing, and clinical outcome correlation to be confirmed in ME/CFS populations.
Tags
Symptom:PainFatigueSensory Sensitivity
Biomarker:MetabolomicsGene ExpressionBlood Biomarker
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- PMID
- 20929047
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →